Cargando…

EIF4EBP1 Overexpression Is Associated with Poor Survival and Disease Progression in Patients with Hepatocellular Carcinoma

OBJECTIVE: EIF4EBP1 acts as a crucial effector in mTOR signaling pathway. Studies have suggested that EIF4EBP1 plays a critical role in carcinogenesis. However, the clinical significance and biological role of EIF4EBP1 in hepatocellular carcinoma (HCC) have not been elucidated. Therefore, we aimed t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cha, Yin-Lian, Li, Pin-Dong, Yuan, Lin-Jing, Zhang, Mei-Yin, Zhang, Yao-Jun, Rao, Hui-Lan, Zhang, Hui-Zhong, Zheng, X. F. Steven, Wang, Hui-Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319970/ https://www.ncbi.nlm.nih.gov/pubmed/25658620 http://dx.doi.org/10.1371/journal.pone.0117493

Ejemplares similares

Overexpression of GINS4 Is Associated With Tumor Progression and Poor Survival in Hepatocellular Carcinoma
por: Zhang, Ziying, et al.
Publicado: (2021)

Overexpressed HDAC4 is associated with poor survival and promotes tumor progression in esophageal carcinoma
por: Zeng, Li-Si, et al.
Publicado: (2016)

CEBPG promotes acute myeloid leukemia progression by enhancing EIF4EBP1
por: Jiang, You, et al.
Publicado: (2021)

EIF4EBP1 is transcriptionally upregulated by MYCN and associates with poor prognosis in neuroblastoma
por: Voeltzke, Kai, et al.
Publicado: (2022)

High expression of autophagy-related gene EIF4EBP1 could promote tamoxifen resistance and predict poor prognosis in breast cancer
por: Yang, Shan, et al.
Publicado: (2023)

eIF4E Overexpression Is Associated with Poor Prognoses of Ovarian Cancer
por: Zheng, Jun, et al.
Publicado: (2020)

MTP18 overexpression contributes to tumor growth and metastasis and associates with poor survival in hepatocellular carcinoma
por: Zhang, Yu, et al.
Publicado: (2018)

Overexpression of p-4EBP1 associates with p-eIF4E and predicts poor prognosis for non-small cell lung cancer patients with resection
por: Tang, Yaoxiang, et al.
Publicado: (2022)

eEF1A1 Overexpression Enhances Tumor Progression and Indicates Poor Prognosis in Hepatocellular Carcinoma
por: Chen, Shi-Lu, et al.
Publicado: (2017)

Metformin blocks MYC protein synthesis in colorectal cancer via mTOR‐4EBP‐eIF4E and MNK1‐eIF4G‐eIF4E signaling
por: Shen, Peng, et al.
Publicado: (2018)

Overexpression of microRNA let-7 correlates with disease progression and poor prognosis in hepatocellular carcinoma
por: Shi, Wenxia, et al.
Publicado: (2017)

Overexpression of eIF3D in Lung Adenocarcinoma Is a New Independent Prognostic Marker of Poor Survival
por: Wang, Dan, et al.
Publicado: (2019)

VEGF Overexpression Predicts Poor Survival in Hepatocellular Carcinoma
por: Choi, Sae Byeol, et al.
Publicado: (2017)

BRDT is a novel regulator of eIF4EBP1 in renal cell carcinoma
por: Wan, Pei, et al.
Publicado: (2020)

Allele Loss and Down-Regulation of Heparanase Gene Are Associated with the Progression and Poor Prognosis of Hepatocellular Carcinoma
por: Huang, Guo-Liang, et al.
Publicado: (2012)

Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma
por: Lei, Xiong, et al.
Publicado: (2015)

Dyskerin Overexpression in Human Hepatocellular Carcinoma Is Associated with Advanced Clinical Stage and Poor Patient Prognosis
por: Liu, Bei, et al.
Publicado: (2012)

Overexpression of Cullin7 is associated with hepatocellular carcinoma progression and pathogenesis
por: An, Jun, et al.
Publicado: (2017)

eIF4E-eIF4G complex inhibition synergistically enhances the effect of sorafenib in hepatocellular carcinoma
por: Fang, Chao, et al.
Publicado: (2021)

Overexpression of RBM34 Promotes Tumor Progression and Correlates with Poor Prognosis of Hepatocellular Carcinoma
por: Wang, Wei, et al.
Publicado: (2023)

L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival
por: Guo, Xiaodong, et al.
Publicado: (2012)

Expression of EIF5A2 associates with poor survival of nasopharyngeal carcinoma patients treated with induction chemotherapy
por: Huang, Pei-Yu, et al.
Publicado: (2016)

Prostate Tumor Overexpressed 1 Is a Novel Prognostic Marker for Hepatocellular Carcinoma Progression and Overall Patient Survival
por: Chen, Shu-Peng, et al.
Publicado: (2015)

Overexpression of EIF5A2 Predicts Poor Prognosis in Patients with Oral Squamous Cell Carcinoma
por: Lin, Yueh-Min, et al.
Publicado: (2020)

SPC25 overexpression promotes tumor proliferation and is prognostic of poor survival in hepatocellular carcinoma
por: Zhang, Baozhu, et al.
Publicado: (2020)

CBX6 overexpression contributes to tumor progression and is predictive of a poor prognosis in hepatocellular carcinoma
por: Zheng, Hao, et al.
Publicado: (2017)

mTOR downstream effectors, 4EBP1 and eIF4E, are overexpressed and associated with HPV status in precancerous lesions and carcinomas of the uterine cervix
por: Asimomytis, Aristidis, et al.
Publicado: (2016)

The eIF4EBP-eIF4E axis regulates CD4(+) T cell differentiation through modulation of T cell activation and metabolism
por: Istomine, Roman, et al.
Publicado: (2023)

Monitoring flux in signalling pathways through measurements of 4EBP1-mediated eIF4F complex assembly
por: Frosi, Yuri, et al.
Publicado: (2019)

Lnc524369 promotes hepatocellular carcinoma progression and predicts poor survival by activating YWHAZ-RAF1 signaling
por: Zheng, Wei, et al.
Publicado: (2022)

eif4ebp3l—A New Affector of Zebrafish Angiogenesis and Heart Regeneration?
por: Born, Lisa I., et al.
Publicado: (2022)

APE1 overexpression is associated with poor survival in patients with solid tumors: a meta-analysis
por: Yuan, Chun-Ling, et al.
Publicado: (2017)

Overexpression of CHD1L is associated with poor survival and aggressive tumor biology in esophageal carcinoma
por: Liu, Ze-Han, et al.
Publicado: (2017)

Overexpression of CD55 correlates with tumor progression and poor prognosis in gastric stromal tumors
por: Yin, Xiaonan, et al.
Publicado: (2019)

Overexpression of SCAMP3 is an indicator of poor prognosis in hepatocellular carcinoma
por: Zhang, Xinyuan, et al.
Publicado: (2017)

NSUN5 promotes progression and predicts poor prognosis in hepatocellular carcinoma
por: Zhang, Xiao-Wen, et al.
Publicado: (2022)

Overexpression of KLF5 is associated with poor survival and G1/S progression in pancreatic cancer
por: Li, Yilong, et al.
Publicado: (2019)

Cyclin-dependent kinase subunit 2 overexpression promotes tumor progression and predicts poor prognosis in uterine leiomyosarcoma
por: Deng, Yupeng, et al.
Publicado: (2019)

Overexpressed PKMYT1 promotes tumor progression and associates with poor survival in esophageal squamous cell carcinoma
por: Zhang, Qingyi, et al.
Publicado: (2019)

FGF21 alleviates pulmonary hypertension by inhibiting mTORC1/EIF4EBP1 pathway via H19
por: Li, Xiuchun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q6udgso6lkuat5pfp31gq7bj0s